Supernus Pharmaceuticals (SUPN) acquires Sage Therapeutics (SAGE), enhancing its CNS portfolio with Zurzuvae's potential.

Stifel analysts said the deal “feels like an unremarkable outcome for a company that was once one of the hottest stories in ...